Antiphospholipid Syndrome: Clinical Advances in Diagnosis and Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 67
Special Issue Editors
Interests: cardiology; thrombosis; coagulation; antiplatelet therapy; anticoagulant therapy
Interests: antiphospholipid syndrome; antiphospholipid antibodies; systemic lupus erythematosus; immunosuppressive therapy; diagnosis; management
Special Issue Information
Dear Colleagues,
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies, which predispose individuals to arterial and venous thrombosis as well as pregnancy complications. This syndrome can occur either in isolation (primary APS) or in conjunction with other autoimmune diseases, most notably systemic lupus erythematosus (secondary APS).
Recent clinical advances have revolutionized both the diagnosis and management of antiphospholipid syndrome (APS). However, these remain a challenge for clinicians.
This Special Issue is dedicated to the critical contributions of hematologists, rheumatologists, obstetricians, and other specialists for comprehensive management and improving long-term outcomes in patients with APS. The aim of this Special Issue, which will include original papers and reviews, is to provide an up-to-date overview of advances and progress in the treatment of APS, which will aid in the accurate diagnosis and management of this devastating disease to prevent its harmful consequences.
Dr. Mattia Galli
Dr. Alessandra Ida Celia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiphospholipid syndrome
- antiphospholipid antibodies
- systemic lupus erythematosus
- immunosuppressive therapy
- diagnosis
- management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
